Image For Activity Cover
Treatment of Tobacco Use Disorder in Primary Care
SUD 101 Core Curriculum Overview

Curriculum overview:  While healthcare professionals are often on the front lines of treating substance use disorders, most have limited (if any) training in this area. The SUD 101 Core Curriculum was created to provide a foundation of the current research, resources, and support needed to increase healthcare professionals’ competence and confidence in the care of their patients across the continuum of care. This activity, Treatment of Tobacco Use Disorder in Primary Care, is part of the 23-module curriculum. Please see below for a summary of module 7 out of 23:
Module 7 Overview
Title: Treatment of Tobacco Use Disorder in Primary Care  

Jill M. Williams, MD, Professor of Psychiatry; Director, Division of Addiction Psychiatry, Robert Wood Johnson Medical School

Module Description: Tobacco use disorder is still a major cause of preventable death.  Populations with low income, lower education and/or behavioral health comorbidity (mental illness or SUD) use tobacco at higher rates.  Even brief interventions can be effective and should be provided routinely in health care settings. Counseling and medications are both considered first-line treatments and outcomes are better if they are provided together. Assessment of the time to first cigarette use in the morning is a good indicator of level of addiction to tobacco. Tobacco withdrawal causes clinically significant symptoms of agitation, anxiety, restlessness, and impaired concentration that can undermine success in quitting.  Medications are effective in reducing these withdrawal symptoms and at least doubling the smoker’s chance of success in quitting. These medications include nicotine replacement, bupropion and varenicline. These are generally well tolerated and safer than the ongoing use of tobacco.  Varenicline or combination NRT can be considered first line treatments since they are associated with greater success in quitting than other treatments. Use of medications is also associated with reductions in tobacco use that can lead to future quit attempts.  This educational activity will review updates in evidence-based treatments for tobacco use disorder. 

Educational Objectives:

  • Identify the available forms of clinical assessment, including the utility of the Time to First Cigarette measure (TTFC)
  • Demonstrate knowledge of  evidence based pharmacotherapies for tobacco use disorder treatment, highlighting the safety and efficacy of each
  • Describe nicotine replacement treatment dosing and how to enhance its effectiveness in patients
  • Review the role of counseling in increasing the success of quit attempts and describe the Ask, Advise and Refer model for Primary Care
Availability: On-Demand
Expires on Jan 12, 2026
Cost: FREE
Credit Offered:
1 CME Credit
1 PA-CME Credit
1 Other Professionals Credit
1 Nursing Credit
1 Pharmacy Credit
1 IPCE Credit
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.

Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 and grant no. 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

8-Hour DEA Training Inquiries, email PCSS-MOUD.


Powered By